IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MONTI, SARA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.016
AS - Asia 2.361
EU - Europa 1.599
Continente sconosciuto - Info sul continente non disponibili 305
SA - Sud America 273
AF - Africa 47
OC - Oceania 35
Totale 7.636
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.853
SG - Singapore 671
CN - Cina 645
IT - Italia 477
VN - Vietnam 257
HK - Hong Kong 199
GB - Regno Unito 189
BR - Brasile 187
FR - Francia 169
RU - Federazione Russa 167
BD - Bangladesh 161
JP - Giappone 151
DE - Germania 124
CA - Canada 112
IN - India 98
IE - Irlanda 71
ES - Italia 70
NL - Olanda 59
SE - Svezia 50
FI - Finlandia 43
ID - Indonesia 39
CL - Cile 29
AU - Australia 27
TR - Turchia 26
DK - Danimarca 24
MX - Messico 24
BE - Belgio 23
KR - Corea 23
PL - Polonia 22
CH - Svizzera 19
EC - Ecuador 15
AR - Argentina 14
GR - Grecia 13
PT - Portogallo 13
TH - Thailandia 13
PE - Perù 12
AT - Austria 11
EG - Egitto 11
PK - Pakistan 11
TW - Taiwan 11
IL - Israele 10
ZA - Sudafrica 10
CO - Colombia 8
MA - Marocco 8
NZ - Nuova Zelanda 8
SA - Arabia Saudita 7
SI - Slovenia 7
TN - Tunisia 7
BG - Bulgaria 6
RO - Romania 6
UA - Ucraina 6
CZ - Repubblica Ceca 5
IQ - Iraq 5
JM - Giamaica 5
NO - Norvegia 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
HU - Ungheria 4
IR - Iran 4
PH - Filippine 4
RS - Serbia 4
UZ - Uzbekistan 4
CI - Costa d'Avorio 3
JO - Giordania 3
PR - Porto Rico 3
PY - Paraguay 3
UY - Uruguay 3
AZ - Azerbaigian 2
BH - Bahrain 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
EU - Europa 2
KE - Kenya 2
LT - Lituania 2
LU - Lussemburgo 2
LV - Lettonia 2
MN - Mongolia 2
MT - Malta 2
PA - Panama 2
AM - Armenia 1
AO - Angola 1
AW - Aruba 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BS - Bahamas 1
CY - Cipro 1
DZ - Algeria 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KH - Cambogia 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
MF - Saint Martin 1
MY - Malesia 1
Totale 7.327
Salva come PNG Salva come JPEG
Città #
Dallas 489
Ashburn 303
San Jose 281
Singapore 260
Council Bluffs 139
Hong Kong 136
Santa Clara 125
Milan 112
Fairfield 89
Ho Chi Minh City 84
Los Angeles 73
Chandler 71
Redwood City 63
Hefei 60
Dublin 59
Beijing 57
Hanoi 57
Houston 55
Rome 55
Lauterbourg 53
Buffalo 49
New York 49
Woodbridge 49
Princeton 48
Guangzhou 47
Tokyo 47
Wilmington 47
Southend 45
Moscow 41
Seattle 37
Cambridge 36
Delhi 36
São Paulo 36
Frankfurt am Main 34
London 30
Helsinki 27
Chicago 26
Madrid 26
Bengaluru 25
Ann Arbor 24
Boardman 23
Jakarta 23
Santiago 23
Da Nang 21
Des Moines 21
Munich 20
Paris 18
Seoul 17
Montreal 16
Phoenix 16
Shenzhen 16
Winnipeg 16
Naples 15
Toronto 15
Manchester 14
Shanghai 14
Shenyang 14
Ottawa 13
Central District 12
Warsaw 12
Atlanta 11
Boston 11
Florence 11
Hanover 11
San Diego 11
Tianjin 11
Bangkok 10
Columbus 10
Dearborn 10
Nanjing 10
Osaka 10
Amsterdam 9
Brussels 9
Cangzhou 9
Changsha 9
Dong Ket 9
Haiphong 9
Istanbul 9
Jinan 9
The Dalles 9
Athens 8
Hangzhou 8
Lima 8
Mexico City 8
Milwaukee 8
Palermo 8
Salt Lake City 8
Denver 7
Hebei 7
Lappeenranta 7
Lille 7
Porto 7
Quito 7
San Francisco 7
Taiyuan 7
Turku 7
Washington 7
Zhengzhou 7
Bologna 6
Brooklyn 6
Totale 4.061
Salva come PNG Salva come JPEG
Nome #
Randomized controlled trials and real-world data : differences and similarities to untangle literature data 799
20 years of experience with tumour necrosis factor inhibitors : what have we learned? 524
Glucocorticoids versus glucocorticoids plus cyclophosphamide in eosinophilic granulomatosis with polyangiitis with poor-prognosis factors 467
Retrospective evaluation of patient profiling and effectiveness of apremilast in an Italian multicentric cohort of psoriatic arthritis patients 233
Prevalence of Ankylosing Spondylitis Disease Activity Score (ASDAS) inactive disease in a cohort of patients treated with TNF-alpha inhibitors 233
Chronic pain : the burden of disease and treatment innovations 193
Alveolar haemorrhage in ANCA-associated vasculitis : Long-term outcome and mortality predictors 191
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes 164
The multifaceted aspects of interstitial lung disease in rheumatoid arthritis 163
Identification of two autoantigens recognised by circulating autoantibodies as potential biomarkers for diagnosing giant cell arteritis 163
Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data? 157
Pneumocephalus due to granulomatosis with polyangiitis 151
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study) 143
Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment : extending perspective from old to newer drugs 140
The impact of disease extent and severity detected by quantitative ultrasound analysis in the diagnosis and outcome of giant cell arteritis 136
Disease and treatment-related morbidity in young and elderly patients with granulomatosis with polyangiitis and microscopic polyangiitis 135
Interstitial lung disease in microscopic polyangiitis and granulomatosis with polyangiitis: demographic, clinical, serological and radiological features of an Italian cohort from the Italian Society for Rheumatology 128
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 126
Rheumatoid arthritis treatment : the earlier the better to prevent joint damage 126
Perivascular fibrosis and IgG4-related disease : a case report 121
Factors influencing the choice of first- and second-line biologic therapy for the treatment of rheumatoid arthritis : real-life data from the Italian LORHEN Registry 119
Prognostic factors and long-term outcome with anca-associated kidney vasculitis in childhood 118
Humoral and T-cell immune response following three doses of SARS-CoV-2 mRNA vaccine in giant cell arteritis: analysis of a prospective cohort 106
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 105
The use of ultrasound in the management of large-vessel vasculitis: an evolving concept 103
Ultrasound halo sign as a potential monitoring tool for patients with giant cell arteritis: a prospective analysis 102
One year in review 2017: spondyloarthritis 101
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 96
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 93
Fast-Track Ultrasound Clinic for the Diagnosis of Giant Cell Arteritis Changes the Prognosis of the Disease but Not the Risk of Future Relapse 92
The role of extra-corporeal membrane oxygenation (ECMO) in the treatment of diffuse alveolar haemorrhage secondary to ANCA-associated vasculitis : report of two cases and review of the literature 91
Early development of new cardiovascular risk factors in the systemic vasculitides 90
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 89
Factors influencing patient-reported outcomes in ANCA-associated vasculitis: correlates of the Patient Global Assessment 86
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies 86
Remission and Low-Disease Activity in Granulomatosis with Polyangiitis and Microscopic Polyangiitis: Prevalence and Impact on Damage Accrual 86
Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series 86
Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis 83
Development and implementation of the AIDA International Registry for patients with Behçet’s disease 79
The role of Trimethoprim/sulfametoxazole in reducing relapses and risk of infec-tions in ANCA-associated vasculitis: a meta-analysis 78
Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study 76
The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice 70
How I treat idiopathic patients with inflammatory myopathies in the clinical practice 66
Switching from intravenous to subcutaneous formulation of abatacept : different results in a series of 21 patients 64
Updates on the diagnosis and monitoring of giant cell arteritis 63
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 63
Spinal non-Hodgkin’s lymphoma mimicking a flare of disease in a patient with ankylosing spondylitis treated with anti-TNF agents : case report and review of the literature 59
One year in review 2018: psoriatic arthritis 55
Striking abdominal aortic stenosis revealing Takayasu's arteritis 54
Correspondence on EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs 53
One year in review 2019: vasculitis 52
Novel therapies for ANCA-associated vasculitis 51
ANCA-associated vasculitis in childhood: recent advances 50
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis 50
Circulating suPAR levels are affected by glomerular filtration rate and proteinuria in primary and secondary glomerulonephritis 47
2018 Update of the EULAR Recommendations for the Management of Large Vessel Vasculitis 47
One year in review 2018: systemic vasculitis 47
One year in review 2020: vasculitis 47
One year in review 2017: systemic vasculitis 45
Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendations for the management of large vessel vasculitis 43
A new era for the early and non-invasive diagnosis of giant cell arteritis: the use of fast-track ultrasound in clinical practice 43
The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist 35
Immunosuppressive treatments selectively affect the humoral and cellular response to SARS-CoV-2 in vaccinated patients with vasculitis 28
The giant cell arteritis (GCA) ultrasound score (OGUS) at diagnosis and after initial treatment predicts future relapses in GCA patients: results of a multicentre prospective study 23
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: Data from a European multicentre study 20
null 3
Totale 7.636
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.008
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.008
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022335 0 0 32 35 23 19 17 29 22 59 31 68
2022/2023444 59 25 20 35 32 81 18 31 43 18 40 42
2023/2024360 13 34 18 24 76 15 29 34 16 26 37 38
2024/2025914 31 53 17 79 59 54 44 92 70 73 130 212
2025/20264.048 220 185 856 310 352 203 419 209 395 213 287 399
2026/2027582 190 266 126 0 0 0 0 0 0 0 0 0
Totale 7.636